admin
America is watching as a privately held company called Active — led by cofounder and CEO Alex Kwon — quietly built itself into what Forbes and industry trackers estimate is a roughly $100 million-a-year supplier of vape hardware to the country’s biggest cannabis brands. That’s not small-time tinkering; it’s the infrastructure of an industry whose reach has gone from back-alley dispensaries to boardrooms and national supply chains. This story is about more than a clever engineer turned entrepreneur — it’s about an entire sector finding muscle while federal policy remains frozen in indecision.
Kwon’s playbook has been expansion and partnership: Active has moved into the U.K. and Germany and already pulls a chunk of revenue from European partners, with leadership openly predicting the continent could account for a meaningful share of sales as reform spreads. The company supplies hardware to household names in the U.S. cannabis market, and it is negotiating deals to beef up its EU footprint as regulators there loosen restrictions. For Americans who care about jobs, trade, and national policy, this migration of growth overseas is a direct consequence of Washington’s refusal to provide clear rules for the industry at home.
Washington’s paralysis on federal legalization has consequences beyond politics: it drives capital and know-how into jurisdictions that are establishing rules and scaling markets while U.S. companies are hamstrung by banking limits and interstate barriers. That migration was flagged repeatedly by Forbes and industry analysts as European markets promise faster, freer growth than the patchwork U.S. system can offer. If conservative policymakers care about American competitiveness, the sensible response is to either enforce existing federal law consistently or produce a clear, safety-first regulatory pathway — not let ambiguity hand foreign markets to our entrepreneurs.
Don’t be fooled by the glossy growth narrative: the vape and cannabis complex has been mired in lawsuits, patent fights, and murky partnerships that would make any sober regulator raise an eyebrow. Big-money players and international manufacturers have been accused of knocking heads and knocking boots in courtrooms, and the industry’s ties to tobacco interests and deep-pocketed investors only underscore the need for a strict regulatory baseline. Conservatives should be the first to demand transparent corporate governance and accountability, not cheerlead a rollout that prioritizes scale over safety.
There’s also a moral argument for caution. The marketing muscle behind vape hardware and the way top brands package products aim to normalize and expand use — and that has real consequences for young people and public health. Rather than pretending that private-sector growth absolves public duties, patriotic conservatives should insist on protecting children, securing supply chains, and enforcing age verification with the same vigor we demand in other areas of commerce. The absence of federal clarity is not an excuse for inaction; it’s a call to restore common-sense controls.
If Active’s rise teaches anything, it’s that American entrepreneurs will find opportunities wherever rules are favorable, whether that’s in Berlin or Birmingham. That’s fine when free markets and clear law combine to promote responsible innovation; it’s reckless when regulatory fog lets billion-dollar businesses scale before the public has safeguards in place. Conservatives who love free enterprise should also love the rule of law — and it’s high time policymakers choose one or the other so Americans don’t watch our innovations build foreign markets while domestic communities bear the costs.
